Analyst Price Targets — PRTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 13, 2026 10:30 am | — | Stifel Nicolaus | $19.00 | $9.31 | StreetInsider | Prothena (PRTA) Reiterated at Market Outperform by Citizens After Fireside Chat |
| December 1, 2025 10:38 am | Jason Butler | JMP Securities | $19.00 | $10.75 | TheFly | Prothena price target raised to $19 from $11 at Citizens JMP |
| December 1, 2025 9:32 am | — | Deutsche Bank | $19.00 | $10.75 | StreetInsider | Prothena Corp (PRTA) PT Raised to $19 at Citizens: Discovery Engine Successful |
| October 28, 2025 12:14 pm | Yasmeen Rahimi | Piper Sandler | $36.00 | $11.09 | StreetInsider | Prothena Corp (PRTA) PT Raised to $36 as Piper Sandler Remains Bullish |
| October 28, 2025 10:38 am | — | UBS | $36.00 | $11.31 | TheFly | Prothena price target raised to $36 from $15 at Piper Sandler |
| October 7, 2025 12:32 pm | — | H.C. Wainwright | $20.00 | $9.86 | TheFly | Prothena price target raised to $20 from $14 at H.C. Wainwright |
| September 2, 2025 10:36 am | Jason Butler | JMP Securities | $11.00 | $8.27 | TheFly | Prothena price target lowered to $11 from $29 at Citizens JMP |
| August 14, 2024 7:40 am | Jay Olson | Oppenheimer | $62.00 | $19.77 | StreetInsider | Prothena Corp (PRTA) PT Lowered to $62 at Oppenheimer |
| August 9, 2024 6:27 am | Kennen MacKay | RBC Capital | $24.00 | $19.68 | StreetInsider | Prothena Corp (PRTA) PT Lowered to $24 at RBC Capital |
| May 9, 2024 6:32 am | Kennen MacKay | RBC Capital | $28.00 | $23.03 | StreetInsider | Prothena Corp (PRTA) PT Lowered to $28 at RBC Capital |
Latest News for PRTA
Prothena shares climb as late-stage partnered programs advance, milestone payments strengthen finances and its neurodegenerative pipeline continues to expand.
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Sarepta Therapeutics (SRPT) and Prothena (PRTA). But which of these two stocks is more attractive to value investors?
PRTA posted a Q1 profit as a $50M Novo Nordisk milestone payment boosted revenue and improved its 2026 cash outlook.
DUBLIN--(BUSINESS WIRE)---- $PRTA #Prothena--Prothena today reported financial results for the first quarter of 2026 and provided business highlights.
DUBLIN--(BUSINESS WIRE)---- $PRTA #Prothena--Prothena announces Novo Nordisk obtains Fast Track Designation from the U.S. FDA for coramitug (PRX004) in ATTR amyloidosis with cardiomyopathy.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PRTA.
U.S. House Trading
No House trades found for PRTA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.